FDA Investigator Jennifer L Reed
Jennifer L Reed has conducted inspections on 3 sites in 2 countries as of 19 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Sweden
FDA Investigators that have inspected at least one site in common with Jennifer L Reed:
Abby Lmozeke Baker,
Alan L Truong,
Andrey Sarafanov, PhD,
Anthony F Lorenzo,
Burnell M Henry,
Cynthia Jim, CSO,
Deborah M Trout,
Eileen A Liu,
Eliezar Ramos,
Gene D Arcy,
Jacqueline Mdiaz Albertini,
Jie He,
Joan A Loreng,
Joan Johnson,
John M Mcinnis,
Joseph George,
Laurel A Beer,
LCDR Debra Emerson,
Malgorzata G Norton, PhD,
Mariza M Jafary,
Michael C Kennedy, PhD,
Michael J Vardon,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Minh D Phan,
Nancy Kirschbaum, PhD,
Nancy T Waites,
Nobuko H Katagiri,
Olga Simakova, PhD,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paula A Trost,
Prabhu P Raju,
Randa Melhem, PhD,
Rebecca K Olin,
Richard W Thornton,
Scott T Ballard,
Susan M Jackson,
Toyin B Oladimeji,
Yasamin Ameri,
Ze Peng,
Zuben E Sauna, PhD
Jennifer L Reed's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2023 | FDA 483 | BAXALTA US INC. - Form 483, 2023-05-31 |
May, 2023 | FDA 483 Response | BAXALTA US INC. - Form 483R, 2023-06-21 |
January, 2011 | FDA 483 | Octapharma AB - Form 483, 2011-01-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more